Personalized Fertility & Gynaecology
Conceivf, our proprietary AI engine assists the clinician to deliver superior outcomes. It considers biomarkers, gene expressions, growth factors, genetic factors, and comorbidities to personalize fertility and gynecology care.
Personalized dosage based on autologous plasma growth factors, and biomarkers to treat specific fertility and gynecology conditions.
Conceivf is a full stack Reproductive Health Technologies Platform covers Embryo Grading, Hormonal Dosage, IVF Calendar, IVF Prediction Report, FET Calendar et al.
Seragen offers personalized immnunology therapies for complicated and unexplained infertility based on immuno assays, metablomics and epigenetics based markers.
01Driven by data
Speciality Fertility and Gynae Health Records and database built exclusively for reproductive disorders to advance data-driven, decision-making deliver superior clinical outcomes.
02Backed By Research
Our network of collaborators include fertility centers, gynecology clinics, academia, genome scholars, plasma and stem cell scientists who work to gather and analyze data, exchange expert perspectives, and search for discoveries to transform fertility and gynae care.
All Seragen solutions are available at hospitals that uphold highest quality norms as prescribed by International Medical Council. Our point of care givers network adhere to stringent aseptic conditions adhering to NABH compliance and are ISO certified.
Point of Care Therapeutics
Our range of autologous fertility and gynecology therapeutic solutions
Seragen solutions are available at our exclusive high quality nationwide network
By integrating our work with academia and clinicians, we even deeper insights and accelerate possibilities in reproductive health.
Affected by primary infertility, In Vitro Fertilization (IVF) was not successful as the endometrium was thin (never grew beyond 6mm). The pre-treatment thickness was 5.8mm
Affected by primary infertility, and 3 implantation failures owing to thin endometrium (never grew beyond 6mm). The pre-treatment thickness was 5.8mm
Affected by primary infertility, In Vitro Fertilization (IVF) was deemed ineffective as the endometrium was thin (never grew beyond 6mm). The pre-treatment thickness was 6.7mm
Affected by primary infertility, In Vitro Fertilization (IVF) was unsuccessful as the endometrium was thin (never grew beyond 6mm), pre-treatment thickness was 6.7mm
Affected by primary infertility, In Vitro Fertilization (IVF) was unsuccessful, because of problems caused by a thin endometrium (never grew beyond 7mm). The pre-treatment thickness was 7.1mm
Affected by primary infertility, In Vitro Fertilization (IVF) was deemed ineffective, because of the problems caused by a thin endometrium (never grew beyond 7mm)
Ovarian Health Rejuvenation Pioneered
Since the 1950s, medical dogma has insisted women have a limited number of eggs from birth and therefore limited opportunities to conceive. This concept has perpetuated the idea of a biological clock as an immovable obstacle to getting pregnant, especially when compounded by advancing age and medical issues...Read More
Recurrent Pregnancy Loss & Unexplained Infertility
Recurrent pregnancy loss remains “unexplained” in more than 50% of patients. Seragen network of fertility clinics now offer a new testing and reporting platform for the immunological evaluation of miscarriage and infertility. Our protocol can help guide the immune treatment with even more precision...Read More
Stem Cells Led Regeneration Made Easier
Stem cells usage in fertility treatments is long considered useful for the regeneration power it lends to the target cell linegae, tissue or organ. Telomerase activity historically considered corelated to longevity owing to empirical data is also now seen to be useful in regeneration...Read More